Skip to content

REGN

Regeneron Pharmaceuticals, Inc.

Revenue by region

2025, ended Dec 31, 2025

Earlier:

Regions by fiscal year

Regions by fiscal year
Line, in USD2025202420232022
United States10.2B13.2B12.6B6.9B
Rest Of World508M430M324M—
Other3.66B0.60B0.15B5.21B
Earlier
ROW———73M
Total14.3B14.2B13.1B12.2B